✦ LIBER ✦

The development of combination drugs for atherosclerosis

✍ Scribed by Donald M. Black

Book ID: 107533763
Publisher: Current Science Inc.
Year: 2003
Tongue: English
Weight: 125 KB
Volume: 5
Category: Article
ISSN: 1523-3804
DOI: 10.1007/s11883-003-0065-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination drug therapy retards the dev

Combination drug therapy retards the development of rheumatoid atlantoaxial subluxations

✍ Marko H. Neva; Markku J. Kauppi; Hannu Kautiainen; Reijo Luukkainen; Pekka Hanno 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB 👁 2 views

Immune mechanisms in the development of

Immune mechanisms in the development of atherosclerosis

✍ J. Frostegård; Y.H. Huang; J. Rönnelid; R. Wu; L. Schäfer Elinder 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 169 KB

The Potential for Combination Treatment

The Potential for Combination Treatment Using STAT-C Drugs

✍ David L. Wyles 📂 Article 📅 2009 🏛 Current Science Inc. 🌐 English ⚖ 183 KB

Strategy for the development of novel an

Strategy for the development of novel anticancer drugs

✍ Nagahiro Saijo; Tomohide Tamura; Kazuto Nishio 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 170 KB

The development of gold drugs

✍ W.S.R. 📂 Article 📅 1981 🏛 World Gold Council 🌐 English ⚖ 271 KB

Combination of antidepressant drugs: the

Combination of antidepressant drugs: the case of inositol

✍ Boris Nemets; Mendel Fux; Joseph Levine; R. H Belmaker 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Inositol is a second messenger precursor that is effective in depression and obsessive-compulsive disorder via a mechanism different from serotonin reuptake inhibitors. However, controlled trials of inositol combined with serotonin reuptake inhibitors in depression or in reuptake inhibitor resistant